Use of Genotypic Resistance Testing To Guide HIV Therapy: Clinical Impact and Cost-Effectiveness-Reference-Cited by-同舟云学术

Use of Genotypic Resistance Testing To Guide HIV Therapy: Clinical Impact and Cost-Effectiveness

Published:2001-03-20 Issue:6 Volume:134 Page:440
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Weinstein Milton C.¹,Goldie Sue J.¹,Losina Elena¹,Cohen Calvin J.¹,Baxter John D.¹,Zhang Hong¹,Kimmel April D.¹,Freedberg Kenneth A.¹

Affiliation:

1. From Harvard School of Public Health, Boston University School of Public Health, Harvard Medical School, and Massachusetts General Hospital, Boston, Massachusetts; Community Research Initiative of New England, Brookline, Massachusetts; and Cooper Hospital/University of Medicine and Dentistry of New Jersey and Robert Wood Johnson Medical School, Camden, New Jersey.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multidisciplinary approach for people with HIV failing antiretroviral therapy in South Africa;Southern African Journal of HIV Medicine;2024-07-22

2. Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review;Viruses;2023-08-13

3. Seemingly Unrelated Regression Analysis of the Cost and Health-Related Quality of Life Outcomes of the REVAMP Randomized Clinical Trial;Value in Health Regional Issues;2023-05

4. Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1;Journal of Antimicrobial Chemotherapy;2023-02-04

5. Baseline HIV genotype drug resistance testing: is it time for more or less?;AIDS;2022-08-01